Brief: India's Suven Life Sciences Sept-Quarter Profit Rises
14/11/2019 08:46
Nov 14 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* SEPT-QUARTER CONSOL NET PROFIT 633.1 MILLION RUPEES VERSUS
38.7
MILLION RUPEES YEAR AGO
* SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 2.74 BILLION
RUPEES
VERSUS 895.2 MILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE4x2lbf
Further company coverage: SUVP.NS
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees